Grace Therapeutics (GRCE) Proxy filing summary

Executive summary

• Annual meeting scheduled for September 17, 2026, with voting open until September 16, 2026 at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies before September 3, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of five director nominees for a one-year term expiring at the 2027 annual meeting.

• Advisory vote to approve executive compensation as disclosed in the proxy statement.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.

• Advisory vote on the frequency of future say-on-pay votes, with the board recommending an annual vote.

• Provision for other business to be addressed as may properly come before the meeting.

Board of directors and corporate governance

• Five nominees for director: Brian Davis, Vimal Kavuru, Prashant Kohli, George Kottayil, and Edward Neugeboren.

• Board recommends voting in favor of all director nominees.